Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 5.394
Filter
1.
Swiss Dent J ; 134(1): 123-129, 2024 Apr 05.
Article in German | MEDLINE | ID: mdl-38741423

ABSTRACT

A 35-year-old patient presented with a painless, broad-based exophytic lesion in the buccal interdental region between teeth 13 and 14. Despite oral hygiene efforts the lesion persisted for around one year. Radiology excluded bone involvement, and histopathology after excision confirmed a fibromatous epulis, which is characterized by collagen-rich connective tissue. There was no recurrence within one-year follow-up. Surgical removal proved to be efficient.


Subject(s)
Gingival Neoplasms , Humans , Adult , Gingival Neoplasms/surgery , Gingival Neoplasms/pathology , Gingival Neoplasms/diagnosis , Fibroma/surgery , Fibroma/pathology , Fibroma/diagnosis , Male , Diagnosis, Differential , Female
2.
Genes Chromosomes Cancer ; 63(5): e23247, 2024 May.
Article in English | MEDLINE | ID: mdl-38757718

ABSTRACT

Superficial fibromas are a group of mesenchymal spindle cell lesions with pathomorphological heterogeneity and diverse molecular backgrounds. In part, they may be indicators of an underlying syndrome. Among the best-known entities of superficial fibromas is Gardner fibroma, a plaque-like benign tumor, which is associated with APC germline mutations and occurs in patients with familial adenomatosis polyposis (Gardner syndrome). Affected patients also have an increased risk to develop desmoid fibromatosis (DTF), a locally aggressive neoplasm of the deep soft tissue highly prone to local recurrences. Although a minority of DTFs occur in the syndromic context and harbor APC germline mutations, most frequently their underlying molecular aberration is a sporadic mutation in Exon 3 of the CTNNB1 gene. Up to date, a non-syndromic equivalent to Gardner fibroma carrying a CTNNB1 mutation has not been defined. Here, we present two cases of (sub-)cutaneous tumors with a hypocellular and collagen-rich Gardner fibroma-like appearance and pathogenic, somatic CTNNB1 mutations. We aim to differentiate these tumors from other fibromas according to their histological appearance, immunohistochemical staining profile and underlying somatic CTNNB1 mutations. Furthermore, we distinguish them from locally aggressive desmoid fibromatosis regarding their biological behavior, prognosis and indicated therapeutic strategies. Consequently, we call them CTNNB1-mutated superficial fibromas as a sporadic counterpart lesion to syndromic Gardner fibromas.


Subject(s)
Fibroma , beta Catenin , Humans , beta Catenin/genetics , Fibroma/genetics , Fibroma/pathology , Male , Female , Mutation , Middle Aged , Fibromatosis, Aggressive/genetics , Fibromatosis, Aggressive/pathology , Adult , Gardner Syndrome/genetics , Gardner Syndrome/pathology , Germ-Line Mutation
3.
Int J Mol Sci ; 25(9)2024 Apr 29.
Article in English | MEDLINE | ID: mdl-38732067

ABSTRACT

Plexiform fibromyxoma (PF), also referred to as plexiform angiomyxoid myofibroblast tumor, is an exceedingly rare mesenchymal neoplasm primarily affecting the stomach. Herein, we present a case of PF diagnosed in a 71-year-old male with a history of lung cancer, initially suspected to have a gastrointestinal stromal tumor (GIST) of the stomach, who subsequently underwent subtotal gastrectomy. The histopathological and molecular features of the tumor, including mutations in ABL1, CCND1, CSF1R, FGFR4, KDR, and MALAT1-GLI1 fusion, are elucidated and discussed in the context of diagnostic, prognostic, and therapeutic considerations.


Subject(s)
Fibroma , Stomach Neoplasms , Humans , Male , Aged , Stomach Neoplasms/genetics , Stomach Neoplasms/pathology , Stomach Neoplasms/surgery , Stomach Neoplasms/metabolism , Fibroma/genetics , Fibroma/pathology , Fibroma/metabolism , Immunohistochemistry , Mutation , Biomarkers, Tumor/genetics , Gastrectomy
4.
Jt Dis Relat Surg ; 35(2): 377-385, 2024 Apr 26.
Article in English | MEDLINE | ID: mdl-38727118

ABSTRACT

OBJECTIVES: This study aimed to review a 35-year experience with chondromyxoid fibroma at our institution. PATIENTS AND METHODS: The study retrospectively analyzed the records of 31 consecutive patients (17 males, 14 females; mean age: 30.5±15.7 years; range, 6 to 63 years) with chondromyxoid fibroma who were treated between January 1988 and December 2021. The clinical and radiological characteristics of lesions, tumor volume, and recurrence rates were assessed using the tumor archive of the hospital. RESULTS: The mean follow-up duration was 65.9±42.0 months. Pelvis, proximal tibia, and distal femur were the most common sites of localization. The initial surgical treatment was performed on 27 patients at our clinic, while four patients were referred to the clinic after recurrence. The overall recurrence rate was 16.1%. Intralesional curettage was applied to 21 (77.8%) out of 27 patients. The cavity created after curettage was filled with bone graft (autograft or allograft) in 15 (55.5%) cases. Bone cement was applied in four (14.8%) cases. Resection was applied to five (18.5%) patients. In two (7.4%) cases, intralesional curettage alone was performed. One of these two patients experienced recurrence, resulting in a recurrence rate of 50% in this patient group. No recurrence was observed in other treatment groups. CONCLUSION: Intralesional curettage and filling the defect with bone graft or cement were effective for local control in most cases. Curettage alone was associated with high recurrence rates.


Subject(s)
Bone Neoplasms , Curettage , Fibroma , Neoplasm Recurrence, Local , Humans , Male , Female , Retrospective Studies , Adult , Adolescent , Middle Aged , Bone Neoplasms/surgery , Bone Neoplasms/pathology , Bone Neoplasms/diagnostic imaging , Young Adult , Child , Fibroma/surgery , Fibroma/pathology , Curettage/methods , Neoplasm Recurrence, Local/surgery , Neoplasm Recurrence, Local/pathology , Bone Transplantation/methods , Bone Cements/therapeutic use
5.
Clin Imaging ; 109: 110139, 2024 May.
Article in English | MEDLINE | ID: mdl-38574606

ABSTRACT

PURPOSE: To explore the frequency of superior scapular elastofibroma dorsi in a large patient series with elastofibroma dorsi. METHODS: 136 chest CTs from January 2016 to July 2022 reporting elastofibroma dorsi were retrospectively analyzed. Three radiologists assessed the number, size, and location of elastofibroma dorsi. Continuous variables underwent two-tailed t-tests with p < 0.05. Inter-observer agreement was assessed by using Cohen's Kappa values. RESULTS: In 136 patients (mean age, 75.9 +/- 9.8 years; 117 female), 330 elastofibroma dorsi were found. Six (4.4 %) patients had single, 87 (64 %) double, 22 (16.2 %) triple and 21 (15.4 %) quadruple lesions. All single and double lesions were in the inferior scapular regions. 43 (31.6 %) patients had superior scapular lesions in addition to inferior scapular elastofibroma dorsi. Inferior scapular elastofibroma dorsi was significantly larger than superior scapular elastofibroma dorsi. The probability of a right superior lesion was significantly higher in patients with a larger right inferior lesion. Inter-observer agreement was very good for experienced radiologist (κ = 94.1) and good for other radiologists (κ = 79.4 and κ = 78). CONCLUSION: In contrast to current belief, superior scapular elastofibroma dorsi accompanying the typical inferior scapular lesions is not uncommon and can even manifest bilaterally. To the best of our knowledge, this is the first case series reporting prevalence of quadruple elastofibroma dorsi.


Subject(s)
Fibroma , Soft Tissue Neoplasms , Humans , Female , Aged , Aged, 80 and over , Retrospective Studies , Fibroma/diagnostic imaging , Fibroma/pathology , Scapula/diagnostic imaging , Scapula/pathology , Soft Tissue Neoplasms/diagnostic imaging , Soft Tissue Neoplasms/pathology , Thorax/pathology
6.
Praxis (Bern 1994) ; 113(3): 78-82, 2024 Mar.
Article in German | MEDLINE | ID: mdl-38655734

ABSTRACT

INTRODUCTION: Ischaemic stroke results from a sudden interruption of cerebral blood flow, often caused by thrombosis, embolism or hypoperfusion. Rarely, cardiac tumours are the cause of an embolic event. We report on an 80-year-old woman with a cerebral stroke. Successful thrombectomy revealed a histopathologically confirmed papillary fibroelastoma as the embolic source. Although it was not detectable on initial echocardiography, the tumour was discovered by transesophageal echocardiography. This case emphasises the importance of considering primary cardiac tumours as potential sources of emboli in ischaemic stroke. Keywords.


Subject(s)
Echocardiography, Transesophageal , Heart Neoplasms , Humans , Female , Aged, 80 and over , Heart Neoplasms/diagnostic imaging , Heart Neoplasms/surgery , Heart Neoplasms/pathology , Diagnosis, Differential , Thrombectomy , Ischemic Stroke/diagnostic imaging , Ischemic Stroke/etiology , Ischemic Stroke/surgery , Fibroma/surgery , Fibroma/diagnostic imaging , Fibroma/pathology
8.
Pathol Res Pract ; 256: 155236, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38447489

ABSTRACT

BACKGROUND: Ovarian fibromas are benign tumors that can present peculiar morphological features not studied sufficiently. MATERIAL AND METHODS: In this retrospective study, 75 consecutive cases of ovarian fibroma were morphologically compared with 46 thecomas, 16 granulosa cell tumors, and 5 sclerosing stroma tumors for the following factors: the growth pattern as diffuse or nodular, the presence of hyaline plaques, necrosis, keloid-like sclerosis, calcifications, cystic degeneration, fibrous or edematous stroma, prominent vascularity, lutein cells, cellularity, scant or abundant cytoplasm, prominent cell membranes, nuclear grooves, atypia, and mitotic activity. RESULTS: The tumors differed significantly in terms of hyaline plaques presence, nuclear grooves, growth pattern, stroma type, tumor cellularity, cytoplasm, prominence of cell membranes, atypia, mitotic activity, and prominent vascularity. CONCLUSION: Ovarian fibromas can present some maybe unexpected features rather frequently, such as cystic degeneration, hyaline plaques, prominent vascularity, increased cellularity, and some mitotic activity, thus their presence should not always prompt to an alternative diagnosis.


Subject(s)
Fibroma , Granulosa Cell Tumor , Ovarian Neoplasms , Sex Cord-Gonadal Stromal Tumors , Thecoma , Female , Humans , Thecoma/diagnosis , Thecoma/pathology , Retrospective Studies , Ovarian Neoplasms/pathology , Sex Cord-Gonadal Stromal Tumors/pathology , Fibroma/pathology
9.
BMC Oral Health ; 24(1): 347, 2024 Mar 18.
Article in English | MEDLINE | ID: mdl-38500158

ABSTRACT

BACKGROUND: The association of Human Papilloma Virus (HPV) and Human Syncytial Virus (HSV) infection with inflammatory and potentially malignant disorders of the oral cavity (OPMD) is unknown. The aim of this cross-sectional study was to stablish the expression of the p16INK4A and HSV proteins, to test potential correlation between those parameters in biopsies from clinically diagnosed oral lesions. METHODS: Immunochemical analysis of 211 formalin-fixed, paraffin-embedded (FFPE) blocks from 211 individuals was provided. The clinical diagnosis included in the research were Oral lichen planus (N = 30), Oral Leukoplakia (N = 13) Mucocele (N = 25), Erosion/ulceration/ inflammation of mucosa (N = 8), Overgrowth of mucosa (N = 135). RESULTS: Two hundred eleven analyzed FFPE samples resulted with the median age of 58.5 years (the average age 54.0 years and SD ± 17 years). The female/male ratio was 2.3 (69.7% vs 30.3% respectively). All the samples positive for HSV also expressed p16INK4A (p = 0.000), that's showed various levels of association with the diverse clinical diagnosis reaching the higher level in OM 49.1% (29 positive samples) and OLP 30.5% (18). p16INK4A was associated with OLP at 30.5% (18), and fibroma 30.5%. HSV expression was mostly present in fibroma at 47.6% (10 positive samples). CONCLUSION: HSV and p16INK4A positivity in relation to diagnosis of the biopsies showed statistically most often p16INK4A in OLP and fibroma. The results of co-expression of p16INK4A and HSV in mucocele and fibroma in oral mucosa suggest a cooperation between the molecular alterations induced by these two viruses. Squamous papilloma samples positive for p16INK4A were also positive for HSV, suggesting that the putative pro-oncogenic action of HSV could be an early event.


Subject(s)
Carcinoma, Squamous Cell , Fibroma , Mucocele , Papillomavirus Infections , Female , Humans , Male , Middle Aged , Biomarkers, Tumor/analysis , Carcinoma, Squamous Cell/pathology , Cross-Sectional Studies , Cyclin-Dependent Kinase Inhibitor p16/analysis , Cyclin-Dependent Kinase Inhibitor p16/metabolism , Fibroma/complications , Fibroma/pathology , Human Papillomavirus Viruses , Mouth Mucosa/pathology , Mucocele/complications , Mucocele/pathology , Papillomavirus Infections/complications , Adult , Aged
12.
Cardiovasc Pathol ; 71: 107631, 2024.
Article in English | MEDLINE | ID: mdl-38467167

ABSTRACT

Cardiac papillary fibroelastomas (CPFs) are rare benign cardiac tumors more often involving the left-sided valves and related with threatening embolic complications. We report the case of a 35-year-old woman presenting with relapsing-remitting chest pain and elevated cardiac troponins. After a negative coronary angiography, an integrated imaging assessment based on echocardiography and cardiac magnetic resonance showed a pedunculated mass on the aortic valve causing an intermittent obstructive engagement of the right coronary ostium. A tailored surgical treatment was performed and the histopathological examination of the specimen revealed mesenchymal tissue with the characteristics of CPF.


Subject(s)
Aortic Valve , Cardiac Papillary Fibroelastoma , Heart Neoplasms , Myocardial Infarction , Humans , Female , Adult , Aortic Valve/surgery , Aortic Valve/pathology , Aortic Valve/diagnostic imaging , Heart Neoplasms/pathology , Heart Neoplasms/complications , Heart Neoplasms/surgery , Heart Neoplasms/diagnostic imaging , Cardiac Papillary Fibroelastoma/surgery , Cardiac Papillary Fibroelastoma/pathology , Cardiac Papillary Fibroelastoma/complications , Myocardial Infarction/etiology , Myocardial Infarction/pathology , Treatment Outcome , Coronary Angiography , Coronary Vessels/pathology , Coronary Vessels/diagnostic imaging , Coronary Vessels/surgery , Biopsy , Fibroma/pathology , Fibroma/surgery , Fibroma/complications
13.
J Pediatr Orthop ; 44(6): 395-401, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38506396

ABSTRACT

BACKGROUND: Nonossifying fibroma (NOF) and fibrous cortical defect (FCDs), the most common benign pediatric bone lesions, are usually incidental x-ray findings. Surveillance of characteristic lesions has been recommended to monitor for enlargement and assess fracture risk. However, no accepted fracture risk prediction guidelines exist, so indications for prophylactic surgery are unclear. The study's purposes were to (1) characterize the timing of NOF/FCD-associated fractures, (2) quantify the resources devoted to surveillance, and (3) evaluate the potential for surveillance to prevent pathologic fracture. METHODS: A single institution retrospective review was conducted to identify pediatric patients (below 18 y old) with clinical-radiographic documentation of an NOF or FCD diagnosis from 2012 to 2020. Patients who presented with fracture were tallied but excluded from the surveillance analysis. Patients without at least one follow-up visit were also excluded. Lesional radiographic features were characterized on initial imaging. The number of visits and imaging studies devoted to surveillance were tabulated. The number of fractures and prophylactic surgeries were recorded to quantify the potential of surveillance to prevent pathologic fractures. RESULTS: The study population presenting without fracture consisted of 301 patients with 364 lesions with a mean follow-up of 20 months. By contrast, over the same period, 38 patients presented with NOF/FCD associated pathologic fractures. Surveillance included 1037 additional imaging tests over 1311 follow-up visits, or on average, 3.4 imaging studies and 4.4 visits per patient. During surveillance, only 2 (0.55%) lesions fractured. Another 10/364 (2.8%) patients underwent curettage and grafting, suggesting that-at best-the potential for preventing pathologic fracture by surveillance, assuming all 10 patients who underwent surgery would have subsequently fractured along with the 2 documented fractures, is 3.3% of lesions (12/364). CONCLUSIONS: The small number of fractures and surgeries during the follow-up period probably does not justify additional resources for surveillance beyond the initial visit, except in symptomatic patients with large lesions. However, subsequent visits may play a role in educating patients and their families regarding the natural history of these lesions. LEVEL OF EVIDENCE: Prognostic Level II-retrospective study.


Subject(s)
Bone Neoplasms , Fibroma , Incidental Findings , Humans , Child , Retrospective Studies , Male , Female , Adolescent , Fibroma/diagnostic imaging , Fibroma/pathology , Child, Preschool , Bone Neoplasms/diagnostic imaging , Fractures, Spontaneous/diagnostic imaging , Fractures, Spontaneous/etiology , Fractures, Bone/diagnostic imaging , Infant , Fibrous Dysplasia of Bone/diagnostic imaging , Radiography/methods
14.
J Cutan Pathol ; 51(5): 345-347, 2024 May.
Article in English | MEDLINE | ID: mdl-38337148

ABSTRACT

Storiform collagenoma, also known as sclerotic fibroma, is a relatively rare benign cutaneous tumor consisting of a proliferation of fibroblasts that shows increased production of type I collagen. It may appear as a solitary, sporadic lesion, or, especially when multiple, associated with Cowden syndrome. Giant cell collagenoma has a histopathologic appearance similar to that of storiform collagenoma with the addition of floret-type giant cells. Herein, we report the finding of multiple giant cell collagenomas arising in an individual with Cowden syndrome. In a review of the published literature, this histopathologic variant appears to be rarely observed in association with Cowden syndrome.


Subject(s)
Fibroma , Hamartoma Syndrome, Multiple , Skin Diseases , Skin Neoplasms , Humans , Hamartoma Syndrome, Multiple/complications , Hamartoma Syndrome, Multiple/pathology , Skin Diseases/pathology , Fibroma/pathology , Skin Neoplasms/pathology , Giant Cells/pathology
15.
J Pediatr Hematol Oncol ; 46(3): e251-e253, 2024 Apr 01.
Article in English | MEDLINE | ID: mdl-38408159

ABSTRACT

The plexiform fibromyxoma is a rare mesenchymal tumor in adults that generally originates in the antrum of stomach, being its occurrence in pediatric patients exceptional. It was classified as a distinct entity by World Health Organization in 2010. No recurrences and metastases have been documented in many of the reported patients to date, being the surgical treatment curative. We report the case of a 3-month-old infant who presented to the emergency department with an episode of intestinal subocclusion requiring an emergent surgery. During the surgical intervention, a mass was identified in the jejunum, causing partial occlusion of its lumen. The surgical pathology report revealed an infiltrative tumor composed of spindle-shaped cells disposed in a stroma with a plexiform pattern alternating myxoid areas. These findings and the immunohistochemical characteristics of the neoplastic cells led to classify the tumor as a plexiform fibromyxoma. A description of the immunophenotype of this tumor is made and differential diagnosis with other gastrointestinal tumors is also discussed.


Subject(s)
Fibroma , Soft Tissue Neoplasms , Stomach Neoplasms , Humans , Infant , Fibroma/surgery , Fibroma/diagnosis , Fibroma/pathology , Stomach Neoplasms/diagnosis
17.
Br J Oral Maxillofac Surg ; 62(3): 247-251, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38311535

ABSTRACT

This study presents the behavioural findings of central odontogenic fibroma (COF) in a specific ethnic group, analysing treatment methods and demonstrating how involved teeth should be managed in detail. Clinical, radiographic, and histological findings were gathered for 29 patients who visited our clinic, with all patients' data carefully examined by radiologists and reviewed microscopically. The cohort comprised 29 patients, with 16 females and 13 males, having a mean (SD) age of 33.1 (16.0) years. Among them, 19 patients were affected in the maxilla, with 15 showing anterior preference, and palatal depression was observed in six patients. Tooth resorption was evident in 15 patients, while 10 patients showed tooth displacement. Within the cohort, 13 patients underwent tooth extraction and resection, while the remaining 16 did not have teeth extracted. Notably, there was no significant difference in recurrence observed between these two groups. This study represents the largest study to date of COF within a single ethnic group and institution. A subset of cases exhibited noteworthy features of COF. However, intriguingly, despite these characteristics, the preservation of contiguous teeth did not demonstrate a significant impact on recurrence rates.


Subject(s)
Fibroma , Odontogenic Tumors , Humans , Female , Male , Odontogenic Tumors/surgery , Odontogenic Tumors/pathology , Adult , Middle Aged , Fibroma/surgery , Fibroma/pathology , Adolescent , Tooth Extraction , Republic of Korea , Young Adult , Maxillary Neoplasms/surgery , Maxillary Neoplasms/pathology , Child , Neoplasm Recurrence, Local
18.
BMJ Case Rep ; 17(2)2024 Feb 06.
Article in English | MEDLINE | ID: mdl-38320829

ABSTRACT

Fibroadenomas are the most common breast lesion in women of reproductive age. During pregnancy and lactation, fibroadenomas can undergo rapid growth in response to hormonal stimulus. These changes may prompt further investigation and/or intervention due to the risk of an underlying phyllodes tumour. We present a case of a female patient who underwent surgical excision of a giant fibroepithelial lesion at 4 months post partum while continuing to breastfeed. The lesion was successfully excised while maintaining lactation. A postoperative milk fistula resolved with non-operative management. There is limited literature on the surgical management of breast lesions in lactating women. This case illuminates the surgical management of breast lesions in an often well informed group of patients who may choose to have surgery while lactating in spite of the increased risk of complications. This case also highlights the need for a holistic approach to maintain the overall health of mother and child.


Subject(s)
Breast Neoplasms , Fibroadenoma , Fibroma , Neoplasms, Fibroepithelial , Phyllodes Tumor , Pregnancy , Child , Female , Humans , Fibroadenoma/surgery , Fibroadenoma/pathology , Lactation , Breast Neoplasms/surgery , Breast Neoplasms/pathology , Neoplasms, Fibroepithelial/pathology , Breast/pathology , Phyllodes Tumor/pathology , Fibroma/pathology
19.
J Cutan Pathol ; 51(5): 348-352, 2024 May.
Article in English | MEDLINE | ID: mdl-38380692

ABSTRACT

Several cases of elastofibromatous lesion affecting the oral mucosa have been reported. Clinically, these lesions may appear as small exophytic lesions or less often as white lesions. Therefore, fibrous hyperplasia and leukoplakia are not uncommonly considered in clinical differential diagnosis. Microscopically, elastic and fibrous connective tissue deposition is seen. Rarely, elastofibromatous changes can be detected when assessing intraoral lesions, including cysts, salivary gland neoplasms, and epithelial dysplasia. Here we report two oral lesions showing elastofibromatous changes, expanding their clinicopathological spectrum. The first case was a 46-year-old man with a history of asymptomatic nodular lesion on the palate 1 year ago, diagnosed as giant cell fibroma with elastofibromatous changes. The second case was a 79-year-old woman who presented a pigmented and mildly symptomatic lesion on the mandibular alveolar mucosa several months ago, diagnosed as amalgam tattoo associated with elastofibromatous changes.


Subject(s)
Fibroma , Pigmentation Disorders , Tattooing , Male , Female , Humans , Aged , Middle Aged , Pigmentation Disorders/pathology , Mouth Mucosa/pathology , Fibroma/diagnosis , Fibroma/pathology , Giant Cells/pathology
20.
Medicine (Baltimore) ; 103(6): e37135, 2024 Feb 09.
Article in English | MEDLINE | ID: mdl-38335392

ABSTRACT

RATIONALE: Tuberous sclerosis complex (TSC) is a rare autosomal dominant inherited disorder characterized by the development of nonmalignant tissue growths (hamartomas) in various organ systems, often located in the brain, skin, heart, lung and kidneys. The delayed diagnosis could be attributed to low expectation or exposure of physicians to this rare disease. High index of clinical suspicion is required for early diagnosis of rare diseases to prevent adverse outcomes. PATIENT CONCERNS: The first patient, a 27-year-old man, presented with intermittent left flank pain and hematuria of 5 months duration. On examination of the skin and oral cavity, he had fibrous cephalic plaque, facial angiofibromas, ungual fibromas, confetti skin lesions, and intraoral fibromas. A CT scan of the chest, abdomen, and brain displayed cystic lung parenchymal changes and multifocal micronodular pneumocyte hyperplasia, angiomyolipomas in both kidneys, and multiple calcified subependymal nodules (SEN), respectively. The second patient, a 28-year-old woman, presented with a seizure disorder in the last 1 year, and papular and nodular lesions over her face since childhood. On examination of the skin and oral cavity, she had hypomelanotic macules, facial angiofibromas, shagreen patches, ungual fibromas, intraoral fibromas, and dental enamel pits. DIAGNOSES: Definitive diagnosis of TSC was made in both patients using the "2012 tuberous sclerosis complex diagnostic criteria consensus statement." INTERVENTIONS: The first patient was seen by various medical discipline teams, and suggested close follow-up in the "chronic illness clinic" of the hospital. The second patient was scheduled in dermatology clinic for electrocautery for disfiguring facial nodules. OUTCOME: Both patients were scheduled for close follow-up in the hospital. LESSONS: The patients described had TSC using "clinical diagnostic criteria." Under the clinical diagnostic criteria of TSC, 4 of 11 major criteria and 3 of 7 minor criteria are skin features. Hence, awareness on skin features as clinical markers to suspect TSC should be emphasized in resource-limited countries.


Subject(s)
Angiofibroma , Fibroma , Hamartoma , Skin Diseases , Tuberous Sclerosis , Adult , Female , Humans , Male , Angiofibroma/pathology , Fibroma/pathology , Hamartoma/pathology , Hyperplasia/pathology , Skin/pathology , Skin Diseases/diagnosis , Tuberous Sclerosis/complications , Tuberous Sclerosis/diagnosis , Tuberous Sclerosis/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...